Using the 31-gene expression profile assay may help lead to more personalized treatment strategies in patients with cutaneous melanoma, according to Aaron Farberg, MD.
2023
Binimetinib Improves Upon Efficacy of Encorafenib in BRAF-Mutant Melanoma
Adding binimetinib to treatment with encorafenib improves efficacy in patients with BRAFV600-mutant melanoma, according to trial results published in the Journal of Clinical Oncology.
Circulating Tumor DNA Used to Identify Recurrence, Targetable Variants in Late-Stage Melanoma
In a new study appearing in the Journal of Molecular Diagnostics, researchers from the University of
Chronic complications from immunotherapies more prevalent and persistent than previously shown among melanoma survivors
Chronic immunotherapy-related complications are more prevalent and persistent than previously shown among melanoma survivors, according to new research published Aug. 3 in JAMA Network Open.